CN1055843C - Method for prepn. of a medicine for treatment of aplastic anemia - Google Patents

Method for prepn. of a medicine for treatment of aplastic anemia Download PDF

Info

Publication number
CN1055843C
CN1055843C CN95103160A CN95103160A CN1055843C CN 1055843 C CN1055843 C CN 1055843C CN 95103160 A CN95103160 A CN 95103160A CN 95103160 A CN95103160 A CN 95103160A CN 1055843 C CN1055843 C CN 1055843C
Authority
CN
China
Prior art keywords
radix
medicine
aplastic anemia
paeoniae alba
polygoni multiflori
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN95103160A
Other languages
Chinese (zh)
Other versions
CN1132085A (en
Inventor
周宏波
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN95103160A priority Critical patent/CN1055843C/en
Publication of CN1132085A publication Critical patent/CN1132085A/en
Application granted granted Critical
Publication of CN1055843C publication Critical patent/CN1055843C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention provides a method for preparing a medicine for curing aplastic anemia which is an integrative disease symptom caused by partial or total adynamia of myeloid tissues of human bodies and can not be cured by ideal medicines of the existing Chinese and western medicine. The medicine is prepared from red ginseng, antler glue, astragalus root, leatherleaf milletia, radix polygoni multiflori preparata, bigleaf beautyberry leaf, radix paeoniae alba, wolfberry bark, mulberry leaf, agrimony, lalang grass rhizome, pagodatree flower bud, alkanna tinctoria, natural indigo, dodder seed, glycyrrhiza, ligustrum japonium, ecliptae herba and yam through washing, slicing, soaking, decoction, filtration and concentration. The medicine has the functions of increasing marrow and restoring hematopoiesis; the recovery rate of curing the aplastic anemia can reach 91.3%.

Description

A kind of preparation method for the treatment of the aplastic amenia medicine
The present invention relates to a kind of preparation method for the treatment of the aplastic amenia medicine.
Aplastic amenia is the partly or entirely depleted and syndrome that causes of bone marrow tissue of human body with.Existing doctor trained in Western medicine does not also have a kind of this disease of ideal cured substance so far; At present the traditional Chinese medical science treatment this when sick the methods such as nourishing YIN to lower pathogenic fire that adopt more cure the disease, its effect has only the effect of alleviation, and can not effect a radical cure.
The object of the present invention is to provide a kind of preparation method for the treatment of the aplastic amenia medicine.Medicine by this method is prepared into not only can recover the human body hemopoietic function, but also can improve the home of the physiological functions such as existence circulation that purify the blood.
The mode that the present invention realizes is to think that according to theory of Chinese medical science liver,spleen,kidney negative and positive disequilibrium is morbific main cause, liver-heat is root of Dahurian angelica blood not then, and insufficiency of the spleen then biochemical cereal nutrient weakens, and has blood under one's command and haves no right, kidney decreases that then bone marrow is inadequate, hemopoietic function generation obstacle, pyretic toxicity cave in the bone, fry in shallow oil bright marrow, withered and being difficult of bone marrow given birth to, hemopoietic is obstructed, and fresh blood lacks the source, thereby has formed aplastic amenia.The present invention is according to the principle of traditional Chinese medical science Yin Yang balancing, and suppressing liver-YANG blood strengthens spleen and stomach function blood from having under one's command from pacifying Radix Angelicae Dahuricae, and strong kidney bone marrow is from filling, and hemopoietic function is recovered naturally.So adopt the Chinese crude drug Radix Ginseng Rubra, Colla cornus cervi, the Radix Astragali, Caulis Spatholobi, Radix Polygoni Multiflori Preparata, Folium Callicarpae Macrophyllae, the Radix Paeoniae Alba, Cortex Lycii, Folium Mori, Herba Agrimoniae, Rhizoma Imperatae, the Flos Sophorae Immaturus, Radix Arnebiae (Radix Lithospermi), Indigo Naturalis, Semen Cuscutae, Radix Glycyrrhizae, Fructus Ligustri Lucidi, Herba Ecliptae and Rhizoma Dioscoreae are raw material, its weight ratio of respectively selecting materials is a Radix Ginseng Rubra: Colla cornus cervi: the Radix Astragali: Caulis Spatholobi: Radix Polygoni Multiflori Preparata: Folium Callicarpae Macrophyllae: the Radix Paeoniae Alba: Cortex Lycii: Folium Mori: Herba Agrimoniae: Rhizoma Imperatae: the Flos Sophorae Immaturus: Radix Arnebiae (Radix Lithospermi): Indigo Naturalis: Semen Cuscutae: Radix Glycyrrhizae: Fructus Ligustri Lucidi: Herba Ecliptae: Rhizoma Dioscoreae=5-10: 6-12: 20-40: 20-30: 20-25: 30-40: 20-25: 20-30: 10-12: 30-40: 30-40: 20-25: 10-12: 3-6: 15-22: 9-12: 15-20: 30-40: 20-30, again through cleaning, section, soak, classification decocts, filter, concentrate and make oral liquid or capsule forms.
The invention has the advantages that the Chinese medicine of being made by this method can improve the ill physiological function of human body kidney,liver,spleen, increase bone marrow, recover hemopoietic function, can also improve the normal physiological activity environment of blood, through clinical observation, this herbal medicine efficacy height, adaptability is strong, reaches 91.3% for the cure rate of aplastic amenia.
The present invention is further described with embodiment below:
Embodiment 1: the preparation method for treatment chronic aplastic anemia medicine is that the part by weight of selecting materials and selecting materials is a Radix Ginseng Rubra: Colla cornus cervi: the Radix Astragali: Caulis Spatholobi: Radix Polygoni Multiflori Preparata: Folium Callicarpae Macrophyllae: the Radix Paeoniae Alba: Cortex Lycii: Folium Mori: Herba Agrimoniae: Rhizoma Imperatae: the Flos Sophorae Immaturus: Radix Arnebiae (Radix Lithospermi): Indigo Naturalis: Semen Cuscutae: Radix Glycyrrhizae: Fructus Ligustri Lucidi: Herba Ecliptae: Rhizoma Dioscoreae=6: 9: 30: 20: 20: 30: 20: 20: 10: 30: 30: 20: 10: 3: 15: 9: 15: 30: 20, rinse well through tap water again, cut into slices, to cut into slices by immersion hard at the bottom of the matter 30 minutes with clear water, soft immersion is 20 minutes at the bottom of the matter, to steep medicine then and steep liquid and decoct together 20-25 minute, reuse 800 orders filter with top sieve, filtrate is concentrated under 90 ℃-100 ℃ temperature, and spissated degree is that per 257 gram siccatives are made 60 milliliters concentrated solution and formed.And add antiseptic routinely or add Lumbricusization white sugar water liquid, can make oral liquid respectively, per 60 milliliters is 1 bottle of embedding, also can make capsule, it is to add adjuvant in concentrated solution, and adjuvant is selected starch or dextrin for use, and its amount that adds adjuvant is that per 60 milliliters of concentrated solutions add the 30g adjuvant, spray then and make powder, incapsulate.
Embodiment 2: for the preparation method of treatment acute aplastic anemia medicine, it is selected materials with embodiment 1, and the part by weight of respectively selecting materials is a Radix Ginseng Rubra: Colla cornus cervi: the Radix Astragali: Caulis Spatholobi: Radix Polygoni Multiflori Preparata: Folium Callicarpae Macrophyllae: the Radix Paeoniae Alba: Cortex Lycii: Folium Mori: Herba Agrimoniae: Rhizoma Imperatae: the Flos Sophorae Immaturus: Radix Arnebiae (Radix Lithospermi): Indigo Naturalis: Semen Cuscutae: Radix Glycyrrhizae: Fructus Ligustri Lucidi: Herba Ecliptae: Rhizoma Dioscoreae=5: 6: 20: 20: 20: 40: 20: 30: 12: 40: 40: 25: 12: 6: 15: 12: 15: 40: 20, and its following preparation method is cleaned, section, soak, classification decocts, filter, concentrate and make oral liquid or capsule with embodiment 1.
Embodiment 3: for have a delicate constitution patient's the preparation method of aplastic amenia medicine of treatment, it is selected materials with embodiment 1, and the part by weight of respectively selecting materials is a Radix Ginseng Rubra: Colla cornus cervi: the Radix Astragali: Caulis Spatholobi: Radix Polygoni Multiflori Preparata: Folium Callicarpae Macrophyllae: the Radix Paeoniae Alba: Cortex Lycii: Folium Mori: Herba Agrimoniae: Rhizoma Imperatae: the Flos Sophorae Immaturus: Radix Arnebiae (Radix Lithospermi): Indigo Naturalis: Semen Cuscutae: Radix Glycyrrhizae: Fructus Ligustri Lucidi: Herba Ecliptae: Rhizoma Dioscoreae=10: 12: 40: 30: 20: 30: 25: 20: 10: 30: 30: 20: 10: 3: 20: 10: 20: 30: 30, and its following preparation method is cleaned, section, soak, the classification decoction filtering, concentrate and make oral liquid or capsule with embodiment 1.

Claims (1)

1. preparation method for the treatment of the aplastic amenia medicine, it is characterized in that it selects the Chinese crude drug Radix Ginseng Rubra for use, Colla cornus cervi, the Radix Astragali, Caulis Spatholobi, Radix Polygoni Multiflori Preparata, Folium Callicarpae Macrophyllae, the Radix Paeoniae Alba, Cortex Lycii, Folium Mori, Herba Agrimoniae, Rhizoma Imperatae, the Flos Sophorae Immaturus, Radix Arnebiae (Radix Lithospermi), Indigo Naturalis, Semen Cuscutae, Radix Glycyrrhizae, Fructus Ligustri Lucidi, Herba Ecliptae and Rhizoma Dioscoreae are raw material, its weight ratio of respectively selecting materials is a Radix Ginseng Rubra: Colla cornus cervi: the Radix Astragali: Caulis Spatholobi: Radix Polygoni Multiflori Preparata: Folium Callicarpae Macrophyllae: the Radix Paeoniae Alba: Cortex Lycii: Folium Mori: Herba Agrimoniae: Rhizoma Imperatae: the Flos Sophorae Immaturus: Radix Arnebiae (Radix Lithospermi): Indigo Naturalis: Semen Cuscutae: Radix Glycyrrhizae: Fructus Ligustri Lucidi: Herba Ecliptae: Rhizoma Dioscoreae=5-10: 6-12: 20-40: 20-30: 20-25: 30-40: 20-25: 20-30: 10-12: 30-40: 30-40: 20-25: 10-12: 3-6: 15-22: 9-12: 15-20: 30-40: 20-30, again through cleaning, section, soak, classification decocts, filter, concentrate and make oral liquid or capsule forms.
CN95103160A 1995-03-29 1995-03-29 Method for prepn. of a medicine for treatment of aplastic anemia Expired - Fee Related CN1055843C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN95103160A CN1055843C (en) 1995-03-29 1995-03-29 Method for prepn. of a medicine for treatment of aplastic anemia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN95103160A CN1055843C (en) 1995-03-29 1995-03-29 Method for prepn. of a medicine for treatment of aplastic anemia

Publications (2)

Publication Number Publication Date
CN1132085A CN1132085A (en) 1996-10-02
CN1055843C true CN1055843C (en) 2000-08-30

Family

ID=5074623

Family Applications (1)

Application Number Title Priority Date Filing Date
CN95103160A Expired - Fee Related CN1055843C (en) 1995-03-29 1995-03-29 Method for prepn. of a medicine for treatment of aplastic anemia

Country Status (1)

Country Link
CN (1) CN1055843C (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105663684A (en) * 2016-02-29 2016-06-15 张坚斌 Medicine for treating aplastic anemia
CN106038793A (en) * 2016-08-09 2016-10-26 石本奖 Miao ethnomedicine formula for treating hypotension

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1051504A (en) * 1989-11-04 1991-05-22 姜振轩 The compound method and the technology of regeneration powder
CN1014584B (en) * 1989-12-30 1991-11-06 白璋华 Process for prodeucing of composition for curing disease of immune function lack
CN1071582A (en) * 1991-10-12 1993-05-05 龙孟麟 Aplastic anemia is converted into leukemia

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1051504A (en) * 1989-11-04 1991-05-22 姜振轩 The compound method and the technology of regeneration powder
CN1014584B (en) * 1989-12-30 1991-11-06 白璋华 Process for prodeucing of composition for curing disease of immune function lack
CN1071582A (en) * 1991-10-12 1993-05-05 龙孟麟 Aplastic anemia is converted into leukemia

Also Published As

Publication number Publication date
CN1132085A (en) 1996-10-02

Similar Documents

Publication Publication Date Title
CN1047946C (en) Preparation for treating senile diseases
CN1354014A (en) Gongbu ointment
CN101104059A (en) Pedicure five-element health-preserving toxin-expelling tea
CN101204497A (en) Peroral Chinese traditional medicine for aplastic anemia
CN1181849C (en) Gastropathy treating Chinese medicine
CN1840036A (en) Chinese medicinal composite preparation capable of inhibiting growth of tumor cell
CN102872363A (en) Chinese medicinal oral liquid for treating anemia
CN101700341A (en) Biological composition for nourishing kidney and protecting liver and preparation method for oral liquid thereof
CN1055843C (en) Method for prepn. of a medicine for treatment of aplastic anemia
CN1166983A (en) Nutritious oral liquid for improving quality and quantity of woman's milk and preparation method thereof
CN101611865A (en) Health-care tea for activating yang and tonifying qi
CN1125617A (en) Medicine for treatment of aplastic anemia and its preparation method
CN1150908A (en) Preparation of medicine for treating atrophic gastritis
CN1285378C (en) Nourishing wine for regulating human body balance function
CN1408384A (en) Pure traditional Chinese medicine preparation for curing lung cancer
CN1060349C (en) Menstruation-regulating and speckle-removing capsule and preparation thereof
CN1146434C (en) Growth promoter for Children
CN1054999C (en) Multiple-effect blood-enriching oral liquid
CN1259363A (en) Complex prescription capsule for strengthening yang and tonifying kidney and prepn. method thereof
CN1125580A (en) Patent drug for anti-decrepitude
CN1238005C (en) Spot removing and face nursing capsule
CN101584835A (en) Chinese medicament for treating irregular menstruation
CN1389225A (en) Diabetes treating Chinese medicine prepn. and its prepn. process
CN1067266C (en) Shanshen Fengru Medicinal preparation and its production method
CN111480719A (en) Health tea and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee